HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.
Saved in:
| Title: | HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells. |
|---|---|
| Authors: | Zecher BF; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Ellinghaus D; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Schloer S; Leibniz Institute of Virology, Hamburg, Germany., Niehrs A; Leibniz Institute of Virology, Hamburg, Germany., Padoan B; Leibniz Institute of Virology, Hamburg, Germany., Baumdick ME; Leibniz Institute of Virology, Hamburg, Germany., Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Martin MP; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Glow D; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schröder-Schwarz J; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Niersch J; Leibniz Institute of Virology, Hamburg, Germany., Brias S; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Müller LM; Leibniz Institute of Virology, Hamburg, Germany., Habermann R; Leibniz Institute of Virology, Hamburg, Germany., Kretschmer P; Leibniz Institute of Virology, Hamburg, Germany., Früh T; Leibniz Institute of Virology, Hamburg, Germany., Dänekas J; Leibniz Institute of Virology, Hamburg, Germany., Wehmeyer MH; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Poch T; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Sebode M; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Ellinghaus E; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Degenhardt F; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Körner C; Leibniz Institute of Virology, Hamburg, Germany., Hoelzemer A; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Leibniz Institute of Virology, Hamburg, Germany., Fehse B; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Oldhafer KJ; Department of General & Abdominal Surgery, Asklepios Hospital Barmbek, Hamburg, Germany., Schumacher U; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Franke A; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany., Bunders MJ; Leibniz Institute of Virology, Hamburg, Germany.; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schramm C; Ist Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Martin Zeitz Center for Rare Diseases and Hamburg Centre for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Altfeld M; Leibniz Institute of Virology, Hamburg, Germany marcus.altfeld@leibniz-liv.de.; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. |
| Corporate Authors: | International PSC Study Group (IPSCSG) |
| Source: | Gut [Gut] 2024 Jan 05; Vol. 73 (2), pp. 325-337. Date of Electronic Publication: 2024 Jan 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
